Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches.
Ashraf GM, DasGupta D, Alam MZ, Baeesa SS, Alghamdi BS, Anwar F, Alqurashi TMA, Sharaf SE, Al Abdulmonem W, Alyousef MA, Alhumaydhi FA, Shamsi A. Ashraf GM, et al. Among authors: dasgupta d. Molecules. 2022 Jul 21;27(14):4652. doi: 10.3390/molecules27144652. Molecules. 2022. PMID: 35889524 Free PMC article.
Role of lisinopril in the therapeutic management of cardiovascular disease by targeting microtubule affinity regulating kinase 4: molecular docking and molecular dynamics simulation approaches.
Atiya A, Alsayari A, Bin Muhsinah A, Almaghaslah D, Bilgrami AL, Abdulmonem WA, Alorfi NM, DasGupta D, Ashraf GM, Shamsi A, Shahwan M. Atiya A, et al. Among authors: dasgupta d. J Biomol Struct Dyn. 2023 Oct-Nov;41(18):8824-8830. doi: 10.1080/07391102.2022.2143425. Epub 2022 Nov 14. J Biomol Struct Dyn. 2023. PMID: 36376029
Correction: Ashraf et al. Inhibition of Microtubule Affinity Regulating Kinase 4 by Metformin: Exploring the Neuroprotective Potential of Antidiabetic Drug through Spectroscopic and Computational Approaches. Molecules 2022, 27, 4652.
Ashraf GM, DasGupta D, Alam MZ, Baeesa SS, Alghamdi BS, Anwar F, Alqurashi TMA, Sharaf SE, Al Abdulmonem W, Alyousef MA, Alhumaydhi FA, Shamsi A. Ashraf GM, et al. Among authors: dasgupta d. Molecules. 2023 Jan 6;28(2):600. doi: 10.3390/molecules28020600. Molecules. 2023. PMID: 36677971 Free PMC article.
Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.
Atiya A, Das Gupta D, Alsayari A, Alrouji M, Alotaibi A, Sharaf SE, Abdulmonem WA, Alorfi NM, Abdullah KM, Shamsi A. Atiya A, et al. ACS Omega. 2023 Feb 7;8(7):6423-6430. doi: 10.1021/acsomega.2c06634. eCollection 2023 Feb 21. ACS Omega. 2023. PMID: 36844587 Free PMC article.
379 results